MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Cardiovascular
  • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • Videos
    • Whitepapers
  • DeviceTalks
You are here: Home / Business/Financial News / EarlySense lands FDA OK for patient data central display

EarlySense lands FDA OK for patient data central display

October 4, 2010 By MedCity News Leave a Comment

MedCity News logo

Israeli medical device company EarlySense Ltd. announced today that its EverOn Central Display Station — which accompanies its EverOn Touch patient monitoring system — was cleared the Food & Drug Administration.

The 510(k) clearance covers the ability to collect real-time vital sign information from up to three dozen EverOn bedside monitors and display the information on a computer screen at a nurse’s station. The information also is displayed on large LCDs on medical or surgical floors, enabling clinicians to continuously monitor patients.

“Today’s FDA clearance news allows us to provide hospitals with a comprehensive solution that enables proactive patient care,” said EarlySense CEO Avner Halperin in a prepared statement.

“This is achieved by delivering critical vital sign and patient safety information from the bedside to the nurses and physicians, wherever they are," he said. "With today’s increased focus on improved quality and patient safety targets coupled with the challenges of shrinking budgets, hospitals are turning to advanced technologies such as EverOn to provide effective alerts on high risk situations.”

The EverOn Touch patient-supervision system goes underneath a hospital bed mattress. The device measures a patient’s vital signs, such as heart and respiration rates, as well as movements to alert caregivers about his or her medical condition, according to the company.

In late June, EarlySense received FDA clearance to sell its EverOn Touch system in the United States. Earlier that month, EarlySense raised $13 million from mostly Israeli investment firms to launch its improved monitoring system in the United States and Europe. Bridge Investment Fund in Cleveland also is an investor and participated in the recent fundraising round.

The company last year received a grant commitment from the Global Cardiovascular Innovation Center led by the Cleveland Clinic. At that time, EarlySense said it planned to establish a base of operations in the Cleveland area to develop the next version of its patient-monitoring device.

Filed Under: Business/Financial News, News Well, Patient Monitoring, Software / IT Tagged With: EarlySense

In case you missed it

  • Barry out as InspireMD CEO
  • Report: EtO blood levels higher in Illinois neighbors of Medline sterilization plant
  • FDA clears augmented glenoids for Shoulder Innovations system
  • McKesson names new chief information and technology officer
  • Imperative Care raises $85m
  • CMR Surgical appoints new CEO
  • Peregrine Ventures raises $115m
  • Roche wins CE Mark for blood glucose reading smartphone app
  • Cantel Medical beats The Street in Q1 results
  • FDA details framework for abbreviated 510(k) medical device review pathway
  • Drug or device? FDA loses this argument for now
  • Aptar wins FDA clearance for ready-to-use seizure treatment device
  • Aurora Bio touts PET radiotracer data
  • Medical device excise tax would reduce R&D spending, report says
  • Proteus Digital Health restructuring amid reported funding woes
  • GE Healthcare partnering on regenerative tissue manufacturing
  • Schiller issues field safety notice for Tempus LS defibrillators

RSS From Medical Design & Outsourcing

Leave a Reply Cancel reply

You must be logged in to post a comment.

Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Popular Posts

  • Report: SEC probes GE Healthcare, Philips, Siemens in Chinese bribery scheme
  • Edwards Lifesciences warns against below-market mini-tender offer Edwards Lifesciences
  • J&J’s Ethicon files ITC complaint against Intuitive Surgical Intuitive Surgical's EndoWrist instruments
  • Auris Health loses motion to move Intuitive Surgical patent suit from Del. to Cali. Johnson & Johnson's Auris, Intuitive Surgical
  • Enable Injections inks deal with Sanofi for drug delivery platform enfuse-enable-injections
Tweets by @MassDevice
MDO ad

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Follow us on YouTube YouTube

Copyright © 2019 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS